Results 181 to 190 of about 58,791 (313)
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC) [PDF]
Jean El Cheikh +14 more
openalex +1 more source
Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with Hematological Malignancies. [PDF]
Kawamura K.
europepmc +1 more source
Summary Allogeneic haematopoietic stem cell transplantation (ASCT) is a curative treatment for acute myeloid leukaemia (AML) but carries a high risk of gonadotoxicity. Ovarian tissue cryopreservation (OTC) offers a fertility preservation option, yet its safety in AML remains uncertain due to the risk of leukaemic cell reintroduction. The FERTILAM pilot
Augustin Boudry +13 more
wiley +1 more source
Immune cell reconstitution after allogeneic hematopoietic stem cell transplantation in children with β-thalassemia major. [PDF]
Zhou Y +7 more
europepmc +1 more source
Summary Central nervous system (CNS) involvement is a known complication of adult T‐cell leukaemia/lymphoma (ATL), but its clinical characteristics and incidence still remain unclear. This study characterized the clinical features and incidence of CNS involvement in patients with ATL (CNS‐ATL).
Takuya Ueno +11 more
wiley +1 more source
Medication Adherence in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]
Amonoo HL +10 more
europepmc +1 more source
Summary VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) is an X‐linked, systemic, haemato‐inflammatory syndrome caused by somatic mutations in the UBA1 gene. No standardized treatment guidelines exist, but evidence is emerging that treatment with hypomethylating agents (HMAs) can induce improvement of the inflammatory symptoms,
Fieke W. Hoff +3 more
wiley +1 more source

